C. Majerholc

495 total citations
14 papers, 263 citations indexed

About

C. Majerholc is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, C. Majerholc has authored 14 papers receiving a total of 263 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 9 papers in Epidemiology and 4 papers in Virology. Recurrent topics in C. Majerholc's work include HIV/AIDS Research and Interventions (9 papers), HIV, Drug Use, Sexual Risk (7 papers) and HIV Research and Treatment (3 papers). C. Majerholc is often cited by papers focused on HIV/AIDS Research and Interventions (9 papers), HIV, Drug Use, Sexual Risk (7 papers) and HIV Research and Treatment (3 papers). C. Majerholc collaborates with scholars based in France, Finland and Belgium. C. Majerholc's co-authors include David Zucman, Erwan Fourn, Alexandre Vallée, Sophie Caillat‐Zucman, Pierre de Truchis, Jean‐Pierre Aubert, Marc Vasse, S. Bouée, Éric Farfour and Brigitte Bonan and has published in prestigious journals such as PLoS ONE, AIDS and BMC Health Services Research.

In The Last Decade

C. Majerholc

14 papers receiving 259 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Majerholc France 7 123 90 82 63 52 14 263
Melchor Riera Spain 12 226 1.8× 10 0.1× 11 0.1× 131 2.1× 136 2.6× 35 356
Jhon Rojas Spain 11 296 2.4× 2 0.0× 39 0.5× 77 1.2× 141 2.7× 19 355
Ana S. Salazar United States 10 177 1.4× 58 0.6× 12 0.1× 118 1.9× 3 0.1× 34 322
Renzo Flores-Ortiz Brazil 9 126 1.0× 84 0.9× 7 0.1× 17 0.3× 24 0.5× 23 285
Weiran Zheng China 10 42 0.3× 43 0.5× 5 0.1× 31 0.5× 21 0.4× 21 171
Deborah DeVita United States 6 72 0.6× 12 0.1× 19 0.2× 147 2.3× 20 0.4× 8 406
Sukamto Koesnoe Indonesia 8 68 0.6× 49 0.5× 7 0.1× 11 0.2× 1 0.0× 39 190
Nicola Schiano Moriello Italy 11 159 1.3× 13 0.1× 17 0.2× 104 1.7× 4 0.1× 27 266
A. Waters United Kingdom 8 54 0.4× 3 0.0× 38 0.5× 46 0.7× 64 1.2× 9 190
Jamila Aboulhab Singapore 7 198 1.6× 16 0.2× 2 0.0× 46 0.7× 61 1.2× 9 299

Countries citing papers authored by C. Majerholc

Since Specialization
Citations

This map shows the geographic impact of C. Majerholc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Majerholc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Majerholc more than expected).

Fields of papers citing papers by C. Majerholc

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Majerholc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Majerholc. The network helps show where C. Majerholc may publish in the future.

Co-authorship network of co-authors of C. Majerholc

This figure shows the co-authorship network connecting the top 25 collaborators of C. Majerholc. A scholar is included among the top collaborators of C. Majerholc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Majerholc. C. Majerholc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
2.
Vallée, Alexandre, et al.. (2024). Mortality and comorbidities in a Nationwide cohort of HIV-infected adults: comparison to a matched non-HIV adults’ cohort, France, 2006–18. European Journal of Public Health. 34(5). 879–884. 2 indexed citations
3.
Vallée, Alexandre, Julie Trichereau, Erwan Fourn, et al.. (2022). Electronic medical record alert increases HIV screening rates: the Foch hospital pilot POP-up project. BMC Health Services Research. 22(1). 784–784. 1 indexed citations
4.
Zucman, David, et al.. (2022). Monkeypox Vaccine Hesitancy in French Men Having Sex with Men with PrEP or Living with HIV in France. Vaccines. 10(10). 1629–1629. 32 indexed citations
5.
Zucman, David, et al.. (2022). The COVID-19 Pandemic and the Migrant Population for HIV Diagnosis and Care Follow-Up: They Are Left Behind. Healthcare. 10(9). 1607–1607. 6 indexed citations
6.
Vallée, Alexandre, et al.. (2021). COVID-19 Vaccine Hesitancy among French People Living with HIV. Vaccines. 9(4). 302–302. 76 indexed citations
8.
Zucman, David, Olivier Chassany, Christophe Lalanne, et al.. (2019). Patients’ high acceptability of a future therapeutic HIV vaccine in France: a French paradox?. BMC Infectious Diseases. 19(1). 401–401. 4 indexed citations
9.
Farfour, Éric, Philippe Lesprit, Erwan Fourn, et al.. (2018). Acute hepatitis A breakthrough in MSM in Paris area. AIDS. 32(4). 531–532. 6 indexed citations
11.
Farfour, Éric, C. Majerholc, Erwan Fourn, et al.. (2017). Increase in sexually transmitted infections in a cohort of outpatient HIV-positive men who have sex with men in the Parisian region. Médecine et Maladies Infectieuses. 47(7). 490–493. 7 indexed citations
12.
Bouée, S., et al.. (2017). DEPIVIH 2: Use of three HIV testing methods in French primary care settings – ELISA laboratory screening versus two rapid point-of-care HIV tests. Médecine et Maladies Infectieuses. 48(2). 122–129. 5 indexed citations
13.
Tauléra, Olivier, et al.. (2012). Feasibility and acceptability of rapid HIV test screening (DEPIVIH) by French family physicians. Médecine et Maladies Infectieuses. 42(11). 553–560. 11 indexed citations
14.
Zucman, David, et al.. (2007). Prospective Screening for Human Leukocyte Antigen-B*5701 Avoids Abacavir Hypersensitivity Reaction in the Ethnically Mixed French HIV Population. JAIDS Journal of Acquired Immune Deficiency Syndromes. 45(1). 1–3. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026